Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment

Background: Data on the clinical characteristics of premenstrual syndrome (PMS) with co-morbid major depressive disorder (MDD) are scarce. Although selective serotonin re-uptake inhibitors (SSRIs) are widely used to treat both PMS and MDD there is little information on their efficacy in PMS in patie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yakimova R., Stoimenova-Popova M., Chumpalova P., Pandova M., Stoyanova M.
Formato: article
Lenguaje:EN
Publicado: Sciendo 2020
Materias:
R
Acceso en línea:https://doaj.org/article/095ebc5f28aa4dba9c2aa350974659ce
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:095ebc5f28aa4dba9c2aa350974659ce
record_format dspace
spelling oai:doaj.org-article:095ebc5f28aa4dba9c2aa350974659ce2021-12-02T18:16:00ZClinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment0324-175010.2478/amb-2020-0041https://doaj.org/article/095ebc5f28aa4dba9c2aa350974659ce2020-11-01T00:00:00Zhttps://doi.org/10.2478/amb-2020-0041https://doaj.org/toc/0324-1750Background: Data on the clinical characteristics of premenstrual syndrome (PMS) with co-morbid major depressive disorder (MDD) are scarce. Although selective serotonin re-uptake inhibitors (SSRIs) are widely used to treat both PMS and MDD there is little information on their efficacy in PMS in patients with co-morbid MDD.Yakimova R.Stoimenova-Popova M.Chumpalova P.Pandova M.Stoyanova M.Sciendoarticlepmdd/pmsmajor depressive disorderco-morbidityssriMedicineRENActa Medica Bulgarica, Vol 47, Iss 4, Pp 24-30 (2020)
institution DOAJ
collection DOAJ
language EN
topic pmdd/pms
major depressive disorder
co-morbidity
ssri
Medicine
R
spellingShingle pmdd/pms
major depressive disorder
co-morbidity
ssri
Medicine
R
Yakimova R.
Stoimenova-Popova M.
Chumpalova P.
Pandova M.
Stoyanova M.
Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
description Background: Data on the clinical characteristics of premenstrual syndrome (PMS) with co-morbid major depressive disorder (MDD) are scarce. Although selective serotonin re-uptake inhibitors (SSRIs) are widely used to treat both PMS and MDD there is little information on their efficacy in PMS in patients with co-morbid MDD.
format article
author Yakimova R.
Stoimenova-Popova M.
Chumpalova P.
Pandova M.
Stoyanova M.
author_facet Yakimova R.
Stoimenova-Popova M.
Chumpalova P.
Pandova M.
Stoyanova M.
author_sort Yakimova R.
title Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
title_short Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
title_full Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
title_fullStr Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
title_full_unstemmed Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
title_sort clinical characteristics of pms co-morbid with mdd and effectiveness of ssris in its treatment
publisher Sciendo
publishDate 2020
url https://doaj.org/article/095ebc5f28aa4dba9c2aa350974659ce
work_keys_str_mv AT yakimovar clinicalcharacteristicsofpmscomorbidwithmddandeffectivenessofssrisinitstreatment
AT stoimenovapopovam clinicalcharacteristicsofpmscomorbidwithmddandeffectivenessofssrisinitstreatment
AT chumpalovap clinicalcharacteristicsofpmscomorbidwithmddandeffectivenessofssrisinitstreatment
AT pandovam clinicalcharacteristicsofpmscomorbidwithmddandeffectivenessofssrisinitstreatment
AT stoyanovam clinicalcharacteristicsofpmscomorbidwithmddandeffectivenessofssrisinitstreatment
_version_ 1718378315599839232